Commission Implementing Regulation (EU) No 438/2014 of 29 April 2014 approving cyproconazole as an existing active substance for use in biocidal products for product-type 8
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
218/2014 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) No 438/2014 of 29 April 2014 approving cyproconazole as an existing active substance for use in biocidal products for product-type 8
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) nr. 438/2014 frá 29. apríl 2014 um að samþykkja sýprókónasól sem fyrirliggjandi virkt efni til notkunar í sæfivörur í vöruflokki 8
Durchführungsverordnung (EU) Nr. 438/2014 der Kommission vom 29. April 2014 zur Genehmigung von Cyproconazol als alter Wirkstoff zur Verwendung in Biozidprodukten der Produktart 8
Kommisjonens gjennomføringsforordning (EU) nr. 438/2014 av 29. april 2014 om godkjenning av cyprokonazol som eksisterende aktivt stoff til bruk i biocidprodukter av type 8
History
01.11.2014
Adopted JCD confirmed entry into force date
01.11.2014
Compliance date in the EEA
24.10.2014
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
01.08.2014
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
29.04.2014
Adoption date in the EU
20.05.2014
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.